State Street’s Co-Diagnostics CODX Stock Holding History

State Street’s Portfolio CODX Stock Details CODX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$45.9K	Buy	+14,800	New	+$45.5K	﹤0.01%	4063
2026 Q1	–	Sell	-3,355	Closed	-$17K	–	4287
2025 Q4	$17K	Hold	3,355	–	–	﹤0.01%	4252
2025 Q3	$34.6K	Hold	3,355	–	–	﹤0.01%	4196
2025 Q2	$28.2K	Hold	3,355	–	–	﹤0.01%	4170
2025 Q1	$31.2K	Hold	3,355	–	–	﹤0.01%	4153
2024 Q4	$75.5K	Hold	3,355	–	–	﹤0.01%	4047
2024 Q3	$126K	Hold	3,355	–	–	﹤0.01%	3931
2024 Q2	$126K	Hold	3,355	–	–	﹤0.01%	3942
2024 Q1	$113K	Hold	3,355	–	–	﹤0.01%	4015
2023 Q4	$134K	Hold	3,355	–	–	﹤0.01%	3989
2023 Q3	$107K	Hold	3,355	–	–	﹤0.01%	4106
2023 Q2	$112K	Hold	3,355	–	–	﹤0.01%	4205
2023 Q1	$149K	Hold	3,355	–	–	﹤0.01%	4169
2022 Q4	$254K	Buy	3,355 +163	+5%	+$15.3K	﹤0.01%	4014
2022 Q3	$307K	Hold	3,192	–	–	﹤0.01%	3959
2022 Q2	$537K	Sell	3,192 -26	-0.8%	-$3.96K	﹤0.01%	3801
2022 Q1	$597K	Buy	3,218 +435	+16%	+$90.1K	﹤0.01%	3973
2021 Q4	$746K	Sell	2,783 -303	-10%	-$79.5K	﹤0.01%	3884
2021 Q3	$901K	Buy	3,086 +93	+3%	+$27.1K	﹤0.01%	3802
2021 Q2	$741K	Sell	2,993 -11,770	-80%	-$3.03M	﹤0.01%	3724
2021 Q1	$4.22M	Sell	14,763 -359	-2%	-$143K	﹤0.01%	3123
2020 Q4	$4.22M	Sell	15,122 -215	-1%	-$79.7K	﹤0.01%	3044
2020 Q3	$6.25M	Sell	15,337 -533	-3%	-$274K	﹤0.01%	2677
2020 Q2	$9.21M	Buy	+15,870	New	+$7.24M	﹤0.01%	2456

Other funds holding CODX

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PAG

Private Advisory Group Redmond, Washington $1.85B AUM 50.66% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

State Street's CODX Position: Q2 2026 in Review

State Street opened a new position in Co-Diagnostics (CODX) in Q2 2026: 14,800 shares worth $45.9K. The stake represents ﹤0.01% of the portfolio and ranks #4063 among its holdings. This is a return to the name: State Street previously reported a position in CODX as recently as Q4 2025.

State Street first reported a position in CODX in Q2 2020 and has held it in 24 quarters since. The position peaked at $9.21M in Q2 2020. 24 funds tracked by Wall St. Rank hold CODX as of Q2 2026.

State Street held 14,800 shares of Co-Diagnostics worth $45.9K as of Q2 2026.
Co-Diagnostics was a new State Street position in Q2 2026.
Co-Diagnostics made up ﹤0.01% of State Street's portfolio in Q2 2026, its #4063 holding.
State Street first reported a position in Co-Diagnostics in Q2 2020 and has held it in 24 quarters since.
State Street's Co-Diagnostics position peaked at $9.21M in Q2 2020.
24 funds tracked by Wall St. Rank held Co-Diagnostics as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.